GPCR Structure Therapeutics Inc

Price (delayed)

$35.95

Market cap

$2.56B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.03

Enterprise value

$2.29B

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 9
Highlights
The equity has surged by 75% year-on-year but it has declined by 6% since the previous quarter
GPCR's debt is down by 19% YoY but it is up by 8% QoQ
The net income has contracted by 26% from the previous quarter and by 20% YoY
GPCR's quick ratio is down by 21% since the previous quarter

Key stats

What are the main financial stats of GPCR

GPCR stock price

How has the Structure Therapeutics stock price performed over time
Intraday
-2.6%
1 week
1.27%
1 month
-26.77%
1 year
49.73%
YTD
-48.31%
QTD
-33.02%

Financial performance

How have Structure Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$257.81M
Net income
-$214.84M
Gross margin
N/A
Net margin
N/A
The net income has contracted by 26% from the previous quarter and by 20% YoY
GPCR's operating income is down by 23% from the previous quarter and by 17% YoY

Price vs fundamentals

How does GPCR's price correlate with its fundamentals

Growth

What is Structure Therapeutics's growth rate over time

Valuation

What is Structure Therapeutics stock price valuation
P/E
N/A
P/B
1.88
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GPCR's EPS is down by 15% QoQ but it is up by 3.8% YoY
The equity has surged by 75% year-on-year but it has declined by 6% since the previous quarter
GPCR's P/B is 23% less than its last 4 quarters average of 2.5

Efficiency

How efficient is Structure Therapeutics business performance
The ROA has increased by 21% year-on-year but it has declined by 12% since the previous quarter
GPCR's return on equity is up by 21% year-on-year but it is down by 12% since the previous quarter
GPCR's ROIC is down by 10% from the previous quarter but it is up by 9% YoY

Dividends

What is GPCR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GPCR.

Financial health

How did Structure Therapeutics financials performed over time
Structure Therapeutics's total assets has surged by 75% YoY but it has decreased by 5% QoQ
Structure Therapeutics's total liabilities has soared by 60% YoY and by 16% from the previous quarter
GPCR's debt is 100% lower than its equity
The debt to equity has dropped by 100% year-on-year
The equity has surged by 75% year-on-year but it has declined by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.